Pharmalot Ed Silverman Once again, lawmakers introduce a bill to end tax breaks for consumer drug ads. Will it work this time?
Pharmalot Ed Silverman Pharmalittle: Will a small biotech upend the cholesterol market? J&J loses patent protection on key drug
Pharmalot Ed Silverman Pharmalittle: J&J loses a Remicade patent battle: NYC piles on and sues opioid makers
Pharmalot Ed Silverman Pharmalittle: Ohio rejects drug pricing proposal; another insurer tosses OxyContin
Pharmalot Ed Silverman After failed Allergan merger, Pfizer once again considers splitting up the company